Institute acquired an additional site of adjacent to its current site for future expansion. In January 2006, the city of Las Vegas announced plans to work with the Institute, the Bureau of Land Management and other entities to acquire about of land in the city for future use. Clinical research was initiated in 2005 with the opening of Phase I and Phase II clinical trials, including 4 first in human Phase I of investigational drugs. Clinical research and Translational research conducted at NVCI produced a body of work that resulted in 100 publications from NVCI investigators in peer reviewed medical publications (1-100). House Resolution 234, a bill to expand the Institute, was sponsored by Shelley Berkley and co-sponsored by Nevada's two other congressional representatives. It was introduced to the House on January 7, 2009. On December 2, 2011, the institute announced that it entered into an agreement to sell the facility to the UC San Diego Health System as part of a prearranged Chapter 11 bankruptcy filing. On February 1, 2012, the UC San Diego Health System assumed operations of Nevada Cancer Institute's clinical practice. In November 2013, Roseman University completed a merger with the former Nevada Cancer Institute Foundation. UCSD closed its clinic, the UCSD NVCI clinic and flagship building that it had purchased approximately a year previous, and Roseman bought the building and is occupying it while continuing the original mission of NVCI. References External links Cancer Institute UC San Diego Health System UC San Diego Moores Cancer Center Medical research institutes in the United States Buildings and structures in Summerlin, Nevada Medical and health organizations based in Nevada Healthcare in Las Vegas